Results 211 to 220 of about 384,385 (346)

Cross-border logistics risk warning system based on federated learning. [PDF]

Sci Rep
Liang X.
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Experiencing Cultural Safety in Nursing Care: A Focused Ethnography With Refugees. [PDF]

Nurs Health Sci
Nakajima M, Honda I, Doi T.
europepmc   +1 more source

Proposal for a European Parliament and Council Decision amending the Decision of 19 December 1996 adopting an action programme for customs in the Community (Customs 2000). COM (98) 644 final, 11 November 1998 and COM (98) 644 final/2, 16 December 1988 [PDF]

, 1998

core  

Checkpoint blockade and the stem‐like T cell trade‐off

Molecular Oncology, EarlyView.
Stem‐like T cells are key to the success of programmed cell death protein 1 (PD1) blockade, as they sustain long‐term anti‐tumor response by continuously generating effector CD8+ T cells. However, how these cells are maintained in cancer is not fully understood. Hor et al.
Julie M. Mazet, Johanna A. Joyce
wiley   +1 more source

A metagenomic approach for microbial risk assessment and source attribution in high-risk ports of entry environments. [PDF]

Biosaf Health
He X, Zhang R, Dong J, Zhen W, Zhu L, Ren J, Ma X, Wang F, Zhang S, Xu K, Qiu F, Su Q, He J, Zhou W, Wu G.   +14 more
europepmc   +1 more source

Foreign Trade Policy and Apparatus of the People’s Republic of China [PDF]

, 1973
Wang, Kenneth
core   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

PROCEDURES ADMINISTRATIVE RESOLUTION OF CUSTOMS DISPUTES

KELM (Knowledge, Education, Law, Management), 2021
openaire   +1 more source

MBCS: A few-shot intent detection model for manual inspection records. [PDF]

PLoS One
Liao M, Wang Y, Zhang J, Li B, Wan Z.
europepmc   +1 more source